Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
Baltimore, MD – September 10, 2009 – Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company whose personalized oncology services division assists physicians by providing personalized treatment options for their cancer patients, has entered into a collaboration agreement with PinnacleCare, the pioneer and the leading private health advisory company in the world.
PinnacleCare will offer Champions’ personalized oncology services to its members worldwide who have been diagnosed with cancer. Access to Champions’ services will benefit PinnacleCare members, and their physicians, in evaluating personalized options to improve treatment outcomes. Champions’ services offered to PinnacleCare members will include:
- Personalized Oncology Panels comprised of world-renowned experts assembled to assist the client’s physician in determining the optimal treatment, and
- Personalized Tumorgrafts developed from fragments of the client’s living tumor that are surgically removed, propagated and tested to evaluate the effectiveness of potential treatment drugs.
Through this collaboration, Champions will also offer PinnacleCare’s health advisory services to Champions clients. These services include:
- A PinnacleCare health advisor available globally and 24/7 answering client questions, coordinating healthcare schedules, explaining options, arranging treatments, assisting with individual medical experts, staff, and bureaucracies, and available to attend important appointments, and
- PinnacleCare Electronic Health Records including collection, organization, and physician review of client medical records, with all records kept up-to-date and available instantly anywhere in the world for the client and his/her expert healthcare team.
“Champions Personalized Oncology Panels and its Personalized Tumorgraft technology are exactly the kind of cutting edge programs that PinnacleCare seeks for its members,” PinnacleCare Chief Medical Officer, Dr Miles Varn, said. “We believe that the Champions approach to personalized oncology will be of great benefit to our current and prospective members through programs that evaluate treatment options based on the very unique characteristics of each patient’s cancer.”
“PinnacleCare and Champions personalized oncology services complement each other like hand and glove,” said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. “This collaboration will enable us to educate many more physicians regarding our services and assist many more individuals with cutting edge research to personalize their cancer treatment. It will also enhance the individualized services for our clients and provide instant access to state-of-the-art electronic healthcare records for them and their expert healthcare team. We look forward to working closely with PinnacleCare in this high potential collaboration.”